Viveve Medical, Inc. (NASDAQ: VIVE) today announced positive 12-month data from an investigator-initiated, single-arm, 12-month feasibility study using its cryogen-cooled ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE